Bloomberg -- Hospira Inc. (HSP), Fresenius SE (FRE) and Boehringer Ingelheim GmbH are racing to restore U.S. supplies of a leukemia drug while regulators look to imports to meet patient demand. The Food and Drug Administration is working with the three companies to restore manufacturing levels for the medicine, cytarabine, and has found an overseas drugmaker willing to temporarily import the injections, Shelly Burgess, an agency spokeswoman, said yesterday. She declined to name the company because the product hasn’t been approved.
